WEDNESDAY, March 6, 2024 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved the country’s first continuous glucose monitor for type 2 diabetes. The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 and older who have type 2Continue Reading

FRIDAY, Feb. 2, 2024 (HealthDay News) — Women are much more prone than men to develop autoimmune diseases like rheumatoid arthritis, multiple sclerosis and lupus. Now, researchers have come up with a potential explanation for that — one that’s rooted in genes that drive a person’s gender. The female bodyContinue Reading